Baxter International Inc.

BAX · NYSE

BAX has an annual revenue baseline of $11.2B, latest revenue marker of $2.7B Q1 2026, annual net income of -$957M and cash of $2.02B. The thesis depends on revenue durability, margins, cash conversion and balance-sheet discipline.

Follow Add to Watchlist Ask Question

NYSE BAX Coverage Bootstrap Baxter International Inc.

Latest ReportMay 20, 2026Baxter: the hospital-products reset has to turn scale into cleaner earningsView report ->Total Reports1Published reportView all ->Active Discussions0No visible comments yetView discussions ->Member WorkspaceLockedFinancials, timeline, comparisons, scorecard, and discussion require a paid login.View access ->

Company filters1 of 1 reports match

Clear filters

Add tags

Selected tags

NYSECoverage Bootstrap

Clear tags

MatchAny tag All tags

Latest Thesis

Baxter: the hospital-products reset has to turn scale into cleaner earnings

May 20, 2026Research reportSlides available

Read report Open slides Discussion (0)

Baxter International Inc.the hospital-products reset has to turn scale into cleaner earniMay 20, 2026

Member workspace

Financials and workspace tools are for paid members.

Paid login unlocks company financials, filing timeline, peer comparison, scorecard, and discussion. Valuation remains admin-only while we finalize market-data licensing.

Recent Reports

Compact report index for this company.

View all 1 reports ->

ReportTypeUpdatedReadActions

Baxter: the hospital-products reset has to turn scale into cleaner earningsBAX has an annual revenue baseline of $11.2B, latest revenue marker of $2.7B Q1 2026, annual net income of -$957M and cash of $2.02B. The thesis depends on revenue durability, margins, cash conversion and balance-sheet discipline.NYSEMay 20, 2026Research reportRead Slides